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ABSTRACT 
Thrombokin~e is prepared from bovine plasma by a  procedure involving: treat- 
ment with diatomaceous silica,  adsorption on  barium sulfate,  flowing  elution  with 
two  successive  phosphate buffers,  ammonium sulfate fractionation,  "spontaneous" 
activation in concentrated solution,  and isoelectric precipitation. The yield of nitro- 
gem is 0.002 per cent,  corresponding  to  1.2  mg. protein per liter of plasma. 
When diluted  back to  the volume of parent plasma, and  complemented by cal- 
cium  plus  cephalin,  the  product  causes  appreciable activation  of prothrombin  in 
1  minute.  Thus,  the  quantity  of  thrombokinase obtainable  is  compatible with  a 
physiologic  role. In the more complex system used for routine assay, thrombokinase 
can be supplied by crude plasma at a  dilution of 1/500.  In parallel tests, the prod- 
uct  appears to be more active than  its parent plasma, although  it  contains  only 
0.002  per  cent  of  the  nitrogen.  However,  the  thrombokinase of  the  product  has 
been activated, whereas the thrombokinase of the plasma is probably in an inactive 
precursor state. 
When  diluted  back to  the  volume of parent plasma,  to  a  concentration  of 0.2 
microgram nitrogen per ml., thrombokinase can slowly activate prothrombin in the 
presence of  oxalate, and  without  the  addition  of accessory factors.  Activation  of 
prothrombin in the presence of oxalate is faster with higher concentrations of throm- 
bokinase. 
According  to  the  view  developed in  this  laboratory,  thrombokinase  is  an 
enzyme which arises from a  plasma precursor during the coagulation of blood. 
Thrombokinase converts prothrombin to thrombin; and the rate of thrombin 
production  is accelerated by platelets plus  calcium ions.  Prior  statements of 
these views from other laboratories have been acknowledged elsewhere (1, 2). 
In the past, thrombokinase has been prepared from plasma as a crude mate- 
rial in an exploratory study  (3),  and later as a  concentrated  by-product ob- 
tained during the preparation of prothrombin (4). The amount of thromboki- 
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nase obtainable made it possible to outline basic relationships; but it was not 
enough  for more extensive work.  The present paper describes a  method for 
preparing  concentrated  thrombokinase from 21-liter  batches  of plasma. The 
concentrate is one-thousandth the volume of the parent plasma and it contains 
0.002 per cent of the nitrogen; yet its activity can be demonstrated in thousand- 
and millionfold dilutions. 
Concentrated  thrombokinase  can activate prothrombin in  the presence of 
excess oxalate  (4).  This is a  property of considerable theoretical interest.  It 
shows  that  thrombokinase  can  function  without  the  aid  of  such  accessory 
factors as platelets or cephalin, which require ionic calcium. Thus it helps to 
single out thrombokinase as the prime activator of prothrombin. 
Despite its theoretical interest,  this effect has not been widely observed in 
recent years. Therefore it has seemed worth while to outline stepwise the con- 
ditions  necessary  to  elicit  this  property. These  conditions  are not quite  as 
stringent as heretofore thought. If the thrombokinase is sufficiently active and 
sufficiently pure, it is not absolutely necessary that it be tested at high concen- 
tration. It is of particular interest that the present preparations are detectable 
in the presence of oxalate when they are diluted back to the volume of the parent 
plasma. 
EXPERIMENTAL 
Methods and Materials 
Coagulation Tests.--Essentially as described  (3). All tests are performed in a water 
bath at 28°C. Each hatch of fibrinogen  is tested with a working standard of glycer- 
inized  thrombin  (5),  which  in  turn  has  been  standardized  against dry  thrombin 
received  from the National Institutes of Health through the courtesy of Dr. W. G. 
Workman. The batch which  was used for the tests herein illustrated  clotted in 37 
seconds after addition of 0.1  ml.  thrombin, containing 0.5  NIH unit,  to 0.3  ml.  of 
the fibrinogen. 1 Thrombin unitage is  estimated on this basis for Figs.  1 and  2. 
Prothrombin.--Prepared by a  modification  of methods previously outlined  (2, 4). 
For the assay of prothrombin, it is activated in dilute state in a  five re~gent sys- 
tem  (2)  and  tested  against  standardized  fibrinogen.  One  unit  of prothrombin  is 
taken as that amount which  produces  1 NIH unit  of thrombin. 
Buffer for Tests.--Veronal-buffered saline,  pH 7.4  (4). 
Cephalin for Tes~s.--Prepared from bovine brain,  by the  method of Howell  (6). 
0.1 per cent suspension  in buffer used for tests. 
1 The fibrinogen  used  in  this  laboratory  has no  added  acceleratory  agent such 
as acacia; and the end-point is the formation of a  solid,  invertible clot. Consequently 
the clotting time observed with a  given amount of thrombin is considerably longer 
than it is when the fibrinogen  has an added acceleratory agent and  when the end- 
point is the first appearance of fibrin.  The method by which  the fibrinogen  is pre- 
pared may also have an effect. For several reasons,  including  the subjective nature 
of some end-points,  it is desirable  to assay thrombin in terms of a  stable standard. j.  rr.  MILSTONE  667 
"Accelerator."--Bovine  serum, after removal of components adsorbed  by 40 mg. 
barium  carbonate per ml.  1/60  dilution  in buffer used  for tests. 
Buffered  Albumin.--Crystallized  bovine  plasma  albumin,  Armour  and  Co., 
Chicago. Dialyzed at least  3 days against veronal-buffered saline.  0.1  per cent so- 
lution used for tests. 
Oxalated Bovine P/asma.--Obtained from Swift and Co., Chicago, through Sperry 
and Barnes,  Co., New Haven. The writer is indebted to Dr. W. H. Seegers  for ad- 
vising him that this material  is commercially available.  Judged from a  letter from 
Swift and Co., the anticoagulant is similar to that of Seegers, Loomis, and Vandenbelt 
(7); and the final concentration of oxalate is within the range 0.006  to 0.015  M. The 
plasma is received in 50 pound quantities,  frozen in wooden kegs or metal cans. 
Hyflo.--Hyflo super-cel, a grade of diatomaceous silica supplied by Johns-Manville 
Corporation, New York. 
E and D Filter Paper.--The Eaton-Dikeman Company, Mt. Holly Springs, Penn- 
sylvania. 
Barium Sulfate.--~.s.P.,  "Suitable for x-ray diagnosis," Merck and  Co.,  Rahway, 
New Jersey. 
Phosphate-Buffered Sodium Chloride, pH 6.7.-- 
4 ~  NaC1  150 ml. 
0.1 M KH2P04  300  " 
0.1 N NaOH  144  " 
Distilled water  to 6 liters 
0.I  Jt Phosphate, pH 6.6.-- 
Na2HPO4  34.1 gm. 
KH2PO4  49.0  " 
Distilled water  to 6.0 liters 
0.4  ~t Phosphate, pH 6.6.-- 
Na~IPO4  170 gin. 
KH2P04  163  " 
Distilled water  to 6 liters 
0.4 SAS.'Phosphate.-- 
0.4 M phosphate, pH 6.6  1 liter 
(NI-I4)  2SO4  242 gin. 
O.OB x~ Acetate, pH 5.2.~ 
CHsCOONa. 3H20  12.520 gm. 
4 ~  CHsCOOH  7.0  ml. 
Distilled water  to 6.0 liters 
Kjeldahl-Nitrogen  (Non-Dialyzable).--Prior  to  analysis,  a  given  volume of each 
fraction, or of diluted  fraction,  is  dialyzed against  cold 0.4 M phosphate, pH 6.6, 
and  diluted  to  a  suitable  multiple  of the  given volume.  A  sample  of appropriate 
size is digested and distilled  by the micromethod of Hiller,  Plazin, and  Van Slyke 
(8). The distillate is collected and titrated  according to Kunitz  (9). 
The Working Assay 
Although  thrombokinase,  by itself,  can activate  prothrombin,  it  is poten- 
tiated  by calcium  and  cephalin;  and  the  effect  is  further  augmented  by an 668  PREPARATION  OF  PLASMA  THROMBOKINASE 
"accelerator" reagent prepared from bovine serum.  In this complex system, 
minute quantities of thrombokinase can be detected; and when the remainder 
of the system is constant, the rate of thrombin production is determined by the 
amount of thrombokinase (2). 
For present purposes, the thrombin-producing system is composed as follows: 
0.5 ml. prothrombin (34 units), 0.1 ml. cephalin, 0.2 ml. "accelerator," 0.1 ml. 
calcium chloride, and 0.1 ml. of the solution to be assayed for thrombokinase. 
Plasma or plasma derivatives are diluted with buffered albumin before they 
are tested as a source of thrombokinase. In contrast to the previously described 
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FrG.  1.  Thrombin  production  in  a  system  containing  prothrombin,  cephalin, 
"accelerator," and calcium,  with varying dilutions  of plasma as a source of throm- 
bokinase. 
"accelerator" reagent (2), the present one has not been passed through a column 
of diatomaceous earth; and the controls without separately added thrombo- 
kinase show some thrombin production, as illustrated in Fig. 1. Within limits, 
the production of thrombin becomes increasingly faster as increasing amounts 
of plasma are included. In Fig. 1, it is seen that the assay system can respond to 
plasma at a final dilution of 1/2,000. 
The test system makes no special allowance for the strong probability that 
thrombokinase  exists  in  plasma  in  the  form of  an  inactive precursor.  The 
activation of this precursor during the tests probably contributes to the S shape 
of the curves, which is perceptible in Fig. 1 and more pronounced in the plasma 
test of Fig.  2. Even with five reagents in its first stage, the system may not 
control all significant variables. Consequently, the test might well respond to 
factors other than thrombokinase or its precursor. A  three stage test would 
remove some of these limitations, but not all. j.  H.  MILSTONE  669 
The present system does have  the advantage of assaying a  thrombokinase 
preparation at such high dilution as to minimize the effect of contaminants in 
the  preparation.  And  notwithstanding  its  limitations,  the  assay  is  a  useful 
guide to purification. Moreover, it leads to concentrated thrombokinase prepa- 
rations which can be identified in a  more specific manner. 
Preparation of Thrombokinase 
1.  Oxalated Plasma.--A  coil of clean,  bright copper  tubing  is  arranged  so  that 
tap water runs  into it at 37-39°C.,  and  out of it v/a rubber tubing into the sink. 
The coil is placed on the surface of the frozen plasma and pressed down as thaw- 
ing progresses. The 50 pound mass is completely thawed in 80 to 120 minutes; and 
then  cold water is run  through  the coil until the plasma is brought  to 28°C.  The 
pH  of the plasma is  7.0. 
TABLE I 
Kjdda~-Nitrog~  ~  S~c~sive  Steps ~  the Proc~ure 
Product  Volume  Nitrogen  Total nitrogen  Yield of  nitrogen 
1.  Oxalated plasma .................... 
2.  Hyflo filtrate and washings ........... 
3.  Second eluate from BaSO4  ........... 
4.  0.4 to 0.5 SAS fraction .............. 
5.  Activated concentrate ............... 
6.  Redissolved isoelectric precipitate  ..... 
ml. 
21,168 
22,970 
8,064 
3O5 
22 
21.2 
m&./ml. 
10.78 
9.71 
0.023 
0.230 
2.76 
0.191 
mg. 
228,191 
223,039 
185 
70.2 
60.7 
4.05 
per ce~ 
100.0 
97.7 
0.081 
0.031 
0.027 
0.0018 
SAS, saturated ammonium  sulfate. 
The figures for volume and nitrogen are averages, taken from determinations on at least 
two preparations. 
2.  Treatment with Hyflo.--This  darifies the plasma and  probably adsorbs some 
protein. In contrast to results with hyflo under other conditions (4,  10)  very little 
thrombokinase is removed. The plasma is stirred for  10 minutes with 2.2 kg. hyflo 
and filtered on 4  Buchner funnels. Each funnel is prepared with a  No.  615  E  and 
D  filter paper,  23  cm.  in  diameter, precoated with  20  grn. hyflo. The filter cakes 
are packed; and each is washed by drawing 1.5 liters of phosphate-buffered sodium 
chloride, pH  6.7,  through  it.  The  filtrate and  washings are combined and  stirred 
with  1.36  kg.  sodium  chloride. The  pH  is  7.4. 
3.  Adsorption  on Barium Sulfate  and Fractional Elu2ion.--The  salted filtrate is 
stirred with 0.44 kg. barium suLfate,  continuously for 10 minutes. Now 0.3 kg. hyflo 
is added and stirred 1 minute. The slurry is filtered with strong suction on 4 Buchner 
funnels prepared as for  the preceding filtration. The filtrate is discarded. 
The filter cakes are now treated as flat chromatographic columns. Through  each 
cake, 3  L. 0.1  ~  phosphate, pH 6.6,  is drawn  in  15  to 20 minutes.  The operation 
is repeated with another 3 liter portion of 0.1 M phosphate. (A small portion of phos- 
phate is allowed to remain on  the cakes, if the procedure is interrupted for  15  to 
60  minutes at this point).  This process washes out unadsorbed protein and  elutes 670  PREPARATION  OF PLASMA  TIIROMIBOKINASE 
much  of the  adsorbed  prothrombin,  along with  some of the  desired  material.  All 
this is discarded. 
Through each cake, 2 liters  0.4 M phosphate, pH 6.6 is drawn in 20 to 30 min- 
utes,  to yield the second eluate.  Its volume is usually  7.9  to 8.3  liters. 
4.  Ammonium Sulfate  Fractionation.--2  kg. ammonium sulfate is dissolved in the 
second eluate to bring it to 0.4 saturation. After 15 minutes, 80 gin. hyflo is added. 
The well  mixed suspension is filtered on a  Buchner funnel, prepared with a  23 cm. 
E and D  No. 612 filter paper, precoated with 20 gin. hyflo. The filter cake is washed 
with 300 ml. 0.4 SAS:phosphate and discarded. 
The volume of the combined filtrate and washings is usually 8.9 to 9.3 liters, and 
the pit is 6.0. The solution is brought to 0.5 saturation by addition of 0.59 kg. am- 
monium sulfate,  stirred  well  and  stored  overnight at  4°C.  The cold suspension  is 
stirred  with 32  gin. hyflo and faltered  on a  small Buchner funnel, prepared  with a 
9  era.  E  and D  No.  612 paper,  precoated with8 gin. hyflo. Although this is per- 
formed at  the usual  ambient  room temperature,  the last  portion of the filtrate  is 
about  10°C. The pH is 5.9.  The packed cake is extracted at room temperature  by 
drawing 300 ml.  0.4 x~ phosphate,  pH  6.6 through it  in 30 minutes. 
This extract is the 0.4 to 0.5 SAS fraction of Table I. Its pH is 6.2 and its volume 
about 305 ml. It is brought to a little more than 0.5 saturation by 99.5 gin. ammo- 
nium sulfate. Mter the well mixed suspension is allowed to stand for 15 to 30 min- 
utes, the precipitate is collected by centrifugation. 
5.  Activation  of the Concentrate.--The  precipitate is dissolved by stages, in 5 ml. 
distilled  water plus 5 ml. normal sodium hydroxide. The sodium hydroxide is cau- 
tiously added dropwise, 0.5 ml. at a step. At each step, care is taken to assure that 
enough protein is dissolved to prevent overalkalin/zation of the solution. After dilu- 
tion to 22 ml. with distilled witer, the pH of the solution is 8.8. It is stored at 4°C. 
for 6 to 8 days. 
In pilot  studies,  carried  through from plasma  to concentrate in  1 day, activity 
tests  on  the  concentrates  display  S-shaped  curves,  suggesting  that  the  thrombo- 
kinase  is  still  in  the precursor  form.  Such curves are not readily  observable with 
a  2 day preparation; or with a  1 day preparation after aging. But, in all cases,  the 
apparent  thrombokinase  activity,  as  estimated  by  the  working  assay,  increases 
several fold in a few days at 4°C. The amount of thrombin also increases, and then 
diminishes toward the end of the week. The activated concentrate is stored at -23°C. 
At this  temperature  its  activity is  well  preserved  for months. 
6.  Isodectric  Precipitation.--The  thawed  concentrate  is  dialyzed  in  a  rocking 
dialyzer (11)  against distilled  water at 3.5°C.  for 4~ hours, and then diluted  with 
550 ml. cold 0.02  M acetate, pH 5.2.  The very fine precipitate is collected by  cen- 
trifugation at 4°C. 
The supernate,  with pH  5.2  and  specific  conductance 0.0014  to 0.0017  mho  at 
25°C.,  is discarded.  The precipitate is dissolved in 20 ml. cold 0.05  ~  NaCI:0.02 
NazHPO4, (pH 8.7-9.0)  to give a  solution at pH 7.8. The addition  of 550 ml. cold 
0.02  M acetate,  pH  5.2,  reprecipitates  the protein,  which is  collected  by centrifu- 
gation. The precipitate is dissolved in 0.05 ~  NaC1:0.02 ~  Na~HPO4 to give a final 
volume of 21.2  ml.  A  small  amount of insoluble material  is  removed  by centrifu- 
gation.  The  solution,  at  pH  7.7-7.8,  is  stored  at  -23°C. J'.  H.  ~ILSTONE  671 
The Activity of the Product in Relation to Its Physiologic Importance 
It would be hard to consider that a  plasma derivative was physiologically 
important as a clotting factor unless it could be shown that it was present in, 
or obtainable from, plasma in sufficiently large quantity to exercise its proposed 
function. The results of Fig.  1, with unfractionated plasma, suggest that the 
quantity  of  available  thrombokinase  is  quite  sufficient.  But  it  is  especially 
remarkable that the purified thrombokinase can exert an effect when diluted 
back to the original volume of plasma and a few thousand times further. 
T.K7  NITROGEN 
T.K.  ~/soo, ooo  0.000388 
.'~'--  T.K. ~,ooo,  ooo  o.oools4 
T. K. ~ooo,ooo  o.oooog7 
PLASMA  I,/500 
T.K. ~,ooo,ooo  Z  0.000049 
i, 
0  I  .  i  !  I 
o  IO  2 o  30  40 
MINUTES 
FIG. 2.  In the working assay, the purified  thrombokinase (T.K.),  appears to be 
more active than its parent plasma. One ml. T.K. is derived from 1,000 ml. plasma. 
Since product 6 of Table I occupies one-thousandth the original volume of plasma, 
it is back to plasma volume when diluted  1/1,000.  Yet, as seen  in Fig. 2, it exerts 
an effect in the working assay when tested in a final dilution of 1/4,000,000.  Fig.  2 
shows the effect of these dilutions when tested in comparison with their  own parent 
plasma, a  sample of which  had been stored at  -23°C. during the preparation. Al- 
though the oxalate of the plasma does not significantly  interfere at  1/500  dilution, 
the dilutions of thrombokinase are made up to contain a little more added oxalate 
than the comparable dilutions of plasma, calculated on the basis of 0.02 ~  added 
oxalate in  the  1/1,000  dilution  of thrombokinase and  0.015 M oxalate in  the  un- 
diluted plasma. 
It is evident from Fig. 2 that a  1/500,000 dilution of thrombokinase is more 
active than a 1/500 dilution of its parent plasma. This would make the yield of 
activity appear to be more than 100  per cent,  if the tests were strictly com- 
parable. But they are not. Thrombokinase probably exists in the plasma in a 
precursor form, which  needs to be activated during  the course of the assay; 672  PI?EPARATION  OF  PLASMA  THROMBOKINASE 
whereas product 6 contains thrombokinase which has already been activated. 
The difference is reflected in the different shapes of the curves in Fig. 2. 
It is further remarkable that thrombokinase is detectable in minute amount, 
in terms of Kjeldahl-nitrogen. As seen in Fig. 2, product 6 displays conspicuous 
activity when its nitrogen concentration is in the range of 0.0001  microgram 
per ml. This extraordinary result provokes speculation, particularly since these 
ultraminute  amounts are  effective only in  the presence of the  "accelerator" 
reagent, and the contributions of the "accelerator" reagent are not well under- 
TABLE II 
Activity  of Thrombokinase When Diluted back to Original Plasma  Volume and  Tested 
with 34 Units of Prothrombin per MI. 
Mixtures  Period of Incubation 
Test 
No.  Pro  ° 
throm- 
bin 
ml. 
0.5 
0.5 
0.5 
0.5 
0.5 
Ce  h-  "Ac- 
Buffer  a~n  n  celer- 
ator" 
ml.  ral.  ral. 
--  0.1  0.2 
0.1  0.1  0.2 
0.2  0.1  -- 
0.3  0.1  -- 
0.3  ~  -- 
0.8  --  -- 
CaCI, 
ml. 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
Kinase 
ml. 
0.1 
0.1 
0.1 
0.1 
rain.  rain. 
sec.  $¢c. 
30  21 
165  100 
4  8  16 
rain.  rain.  rain. 
sec.  5~C.  $C~. 
19  19  17 
n.c.  n.c.  2,040 
70  57  52 
n.c.  n.c.  n.c. 
855  1,080 1,320 
2,760  2,460  n.c. 
32 
rain. 
I  SeC. 
I 
990 
I  n.C, 
9OO 
3,120 
64 
rain. 
$ec. 
360 
n.c. 
750 
n.c. 
Prothrombin, stock solution containing 67.3 units per ml. 
Kinase, product 6,  (see Table I),  diluted 1/100 in buffered albumin. 
At the specified times, 0.1 ml. of mixture was added to 0.3 ml. oxaiated fibrinogen. The 
resulting clotting times are given in the body of the table. A vacant place indicates that 
no sample was tested at the particular time. 
n.c., no clot in 3600 seconds. 
stood. It may further be recalled that thrombokinase can function autocatalyti- 
cally; and thus it can be effective in minute amount in those systems which 
contain prothrombokinase  (4). 
Whatever the explanation might be, it is desirable to examine product 6 in 
further tests, some of which do not include the "accelerator" reagent. Table II 
shows what thrombokinase does when diluted 1/100, then ten times further, to 
original  plasma  volume.  In  these  tests  the  thrombokinase-nitrogen is  0.194 
microgram per ml. As seen in Test 1, it causes considerable activation of pro- 
thrombin within the  1st minute.  In Test 2 thrombokinase has been omitted; 
and the production of thrombin is a few hundred times slower.  That thrombin 
is produced at all in Test 2, indicates that some thrombokinase is available in 
the test  system. This is no longer evident in Test 4,  from which the "accel- 
erator" reagent has been omitted. Nevertheless,  Test 3 shows that thrombo- j.  ~.  m~S~O~CE  673 
kinase can still cause appreciable activation of prothrombin in the 1st minute, 
without the aid of the "accelerator" reagent. 
When it is considered that much of the potential activity is discarded and 
otherwise lost during the preparation of thrombokinase from plasma, and when 
it is seen how rapidly the product can function when diluted back to plasma 
volume, there is little doubt that thrombokinase is obtainable from plasma in 
sufficient quantity to be of physiologic significance. 
The  Yield of Thrombokinase in Relation to Its Action in the Presence of Oxalate 
Previous studies on this phenomenon have emphasized  basic relationships 
(2, 4) and have shown that, if the thrombokinase were concentrated enough, 
it could activate prothrombin moderately fast in the presence of oxalate (12). 
The following  experiments demonstrate this activity in terms of the amount 
obtainable from plasma. They further reveal that this effect may not be mani- 
fest if: (a) the thrombokinase is obscured by too much contaminating throm- 
bin,  (b) the incubation period is too short,  (c) the concentration of substrate 
prothrombin is too low, (d) the concentration of thrombokinase is too low. 
In the course of the preparation,  the effect is not readily demonstrable with 
product  5,  because there  is  too much  thrombin.  Most of that  thrombin  is 
removed in  the next step,  but enough remains  in product  6  to  confuse the 
issue,  temporarily. With the system of Table II, the clue can easily be over- 
looked. Test 5 suggests that thrombokinase is activating the prothrombin and 
slowly outpacing a  simultaneous loss of thrombin.  But this is dubious, even 
though the amount of thrombin is large compared with that revealed by Test 6 
to be present in the thrombokinase preparation. 
In Table III, the kinase is again diluted back to plasma volume. But now the 
concentration of prothrombin is increased to 300 units per ml. Test 1 shows a 
slow, but now quite definite,  production of thrombin. Test 2 shows a parallel 
production of thrombin when calcium is omitted; and Test 3 shows a compara- 
ble effect when oxalate is added. As previously demonstrated in similar experi- 
ments (12) the faster clotting times in Test 1 reflect the influence  of calcium 
on the clotting of fibrinogen. They are not due to faster production of thrombin, 
in this particular system. (Calcium would cause a pronounced acceleration of 
thrombin production in a  cephalin-containing  system.) Test 4 again reveals 
the presence of thrombin in the kinase preparation.  Test 5 is a control on the 
prothrombin reagent. 
If now, the concentration of thrombokinase is increased tenfold, as in Table 
IV, the rate of thrombin production is correspondingly increased,  in the pres- 
ence of calcium,  (Test 1), and in the presence of oxalate, (Test 3). Now, how- 
ever, the thrombin which contaminates the kinase preparation becomes more 
conspicuous,  as in Test 4; and another possibility presents itself.  It might be 
supposed that  it  is  not the kinase,  but  the contaminating  thrombin,  which 674  PREPARATION  O1  ~'  PLASMA  THItOM'BOKINASE 
activates prothrombin in the presence of oxalate. It has previously been shown 
that this is not so (4), but it is desirable to repeat the demonstration with the 
new preparation of thrombokinase. 
TABLE III 
Activity of Thrombokinase  When Diluted  back to Original Plasma  Volume and  Tested 
with 300 Units of Prothrombin per Ml. 
Mixtures  Period of incubation 
Test 
No.  Pro- 
thrombin 
0.5 
0.5 
0.5 
0.5 
Buffer 
m/. 
0.3 
0.4 
0.3 
0.8 
0.4 
CaCh 
ml. 
0.1 
0.1 
0.1 
I Oxalate 
ml. 
0.1 
Kinase 
mL 
0.1 
0.1 
0.1 
0.1 
10 
rain. 
se#. 
770 
2,100 
2,640 
3,240 
rl.¢. 
2o 
rain. 
$$C, 
640 
1,740 
1,980!  1,120 
2,940  I 3,240 
n.c.  ! 
40  8O  1~ 
min.  mln.  min. 
$¢¢.  sec.  $~. 
430  225  120 
1,000  560  250 
680  280 
3,600  n.c. 
n.c.  n.c.  n.e. 
Prothrombin,  stock solution containing 600  units per ml. 
Kinase, product 6~  (see Table I), diluted 1/100  in buffered  albumin. 
CaCI¢, 0.025 xf. 
Oxalatel 0.1 •  potassium oxalate. 
TABLE IV 
Activity of Thrombokinase  When Diluted  back to One-Tenth  Original  Plasma  Volume 
Mixtures  Period  of incubation 
Test 
No.  Pro- 
thrombin 
ml. 
0.5 
0.5 
0.5 
0.5 
Bullet 
ral. 
0.3 
0.4 
0.3 
0.8 
0.3 
CaCh  Oxalate 
mL  ~/. 
0.I 
--  0.1 
0.I 
0. I 
Albumin' 
~nt. 
0.1 
Kinase 
0.i 
0.1 
0.1 
0.1 
10  20  40 
min.  min.  mln. 
SgC,  $~.  $~. 
94  59  34 
160  108  70 
164  118  69 
195  195  240 
n.c.  n.c.  n.c. 
8o 
rain. 
SEA:. 
22 
38 
44 
258 
n.c. 
Prothrombin, stock solution containing 600 units per ml. 
Kinase, product 6,  (see Table I), diluted 1/10  in buffered  albumin. 
Oxalate, 0.1 ~ potassium oxaiate. 
To  18.8  ml. of product 6,  28.2  ml. saturated ammonium sulfate is added to 0.6 
saturation.  The  precipitate is  collected by  centrifugation and  dissolved in  20  ml. 
phosphate-buffered sodium chloride, pH 6.7.  Insoluble material is removed by  cen- 
trifugation, and  16,4  ml. saturated ammonium sulfate is added to  0.45  saturation. 
The precipitate is collected by  centrifugation and dissolved in 20  ml. of phosphate- 
buffered sodium chloride solution. Precipitation at 0.45  saturation  with ammonium 
sulfate is repeated six times. The seventh precipitate is dissolved in 5  ml. phosphate- 
buffered  sodium  chloride  solution  and  dialyzed  against  veronal-buffered  saline. j.  H.  MTLSTONE  675 
Before testing,  it is diluted so that 1 ml. corresponds to 1 ml. of product 6.  Much 
thrombokinase is discarded, or otherwise lost during this procedure. 
In Test 1 of Table V, the reprecipitated thrombokinase is seen to activate 
prothrombin in the presence of oxalate at a faster rate than that of Test 3 in 
Table IV. Contrariwise, the thrombokinase of Table IV contains at least 15 
times as much thrombin (Test 4) as that of Table V (Test 2). As seen in Test 2 
of Table V, the thrombin has been reduced below the limits of the test. 
In summary, the present preparation of thrombokinase can be diluted back 
to original plasma volume and still activate prothrombin in the presence of 
oxalate.  Activation is  faster  with  higher  concentrations  of  thrombokinase, 
and does not depend on the presence of thrombin as a contaminant. 
TABLE V 
Activity  of Thromboldnase  after  Further  Removal  of Thrombin 
Mixtures  Period of incubation 
Test No. 
40 rain. 
0.s  o3  I  o.1  I  o.1 
-  i  o.8  j  o.1  I  o.1 
5mln.  /  10  min_______ I  20  min____ 
n.c.  j  n.c.  j  n.c.  / 
$~C. 
32 
n.c. 
Prothrombin,  stock solution  containing  600 units per ml. 
Oxaiate, 0.1 M potassium oxalate. 
Kinase, product 6 was precipitated  once at 0.6 and seven times at 0.45 saturation with 
ammonium sulfate. 
n.c.,  no clot in 3600 seconds. 
DISCUSSION 
The main purpose of the present work was to develop a method which would 
yield enough purified and concentrated thrombokinase for further study. The 
present product is neither final nor fully characterized. It is known to contain 
thrombin and may contain other factors. There is some evidence (3, 4)  that 
thrombokinase  is  produced  autocatalytically from  a  precursor.  It  is  also 
advisable to contemplate a  thrombokinase-inhibitor complex similar to that 
formed by trypsin and trypsin-inhibitor (13). How much of such inactive forms 
might occur in the present product is a matter for future inquiry. 
The accumulating results have a  pertinent relation to  the  "spontaneous" 
activation of prothrombin preparations. This phenomenon was observed, under 
various conditions, by Cekada in  1926  (14),  by Mellanby in  1933 (15),  by 
Mellanby and Pratt in 1940 (16),  by the writer in 1942 (5), and by Ware and 
Seegers  in  1948 (17).  In  the  last  three  instances,  it  was  reported  that  the 
"spontaneous" activation occurred in the presence of calcium-binding agents 
such as oxalate or citrate. It follows that, if such activation were not truly 676  PREPARATION  OF  PLASMA  THROMBOKINASE 
spontaneous, but induced by a contaminating thrombokinase, then the throm- 
bokinase must be capable of acting in the presence of oxalate or citrate. It 
further follows that if such a  thrombokinase were to be found, a  likely place 
would be those preparations in which "spontaneous" activation of prothrombin 
had occurred. Such preparations would, of course, also contain thrombin. 
The foregoing theoretical consequences have been tested and found to be 
true. In 1949 (18), a "spontaneously" activated fraction was split into a "con- 
verter" subfraction and a  thrombin subfraction. In 1951 (4),  the "converter" 
was identified as thrombokinase and shown to  activate prothrombin in the 
presence of oxalate. At step 5 of the present method, there is again a mixture 
of thrombokinase and thrombin, resulting from "spontaneous" activation. At 
the next step, most of the thrombin remains in solution when the thrombo- 
kinase is subjected to isoelectric precipitation at pH 5.2. The ratio of thrombin 
to thrombokinase can further be reduced by repeated precipitation of the kinase 
by 0.45 saturated ammonium sulfate. 
Activation of prothrombin in the presence of oxalate can be induced by the 
present thrombokinase at a concentration of 0.194 microgram nitrogen per ml., 
corresponding to about 1.2 microgram protein per ml. From this it may be 
estimated that a prothrombin solution containing more than 120 micrograms 
protein per ml. would need to have less than 1 per cent of its protein in the 
form of contaminating thrombokinase, in order to become activated "spon- 
taneously" in the presence of oxalate. The required amount of contamination 
would undoubtedly vary with the conditions. 
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